In addition, oral administration of SK-216 was shown to limit the development of BLM-induced pulmonary fibrosis in mice, suggesting that inhibition of PAI-1 in vivo exerts an antifibrotic effect. The gene discussed is SERPINE1; the disease is pulmonary fibrosis.